| 1 |
Dasatinib, a second-generation tyrosine kinase inhibitor, induces melanogenesis via ERK-CREB-MITF-tyrosinase signaling in normal human melanocytes
Kang B, Kim Y, Park TJ, Kang HY
Biochemical and Biophysical Research Communications, 523(4), 1034, 2020 |
| 2 |
Inhibition of Akt/mTOR pathway overcomes intrinsic resistance to dasatinib in triple-negative breast cancer
Haga Y, Higashisaka K, Yang LL, Sekine N, Lin Y, Tsujino H, Nagano K, Tsutsumi Y
Biochemical and Biophysical Research Communications, 533(4), 672, 2020 |
| 3 |
Micelles entrapped microparticles technology: a novel approach to resolve dissolution and bioavailability problems of poorly water soluble drugs
Parvataneni DM, Devraj R, Mangamoori LN
Journal of Microencapsulation, 37(3), 254, 2020 |
| 4 |
Simultaneous determination of doxorubicin and dasatinib as two breast anticancer drugs uses an amplified sensor with ionic liquid and ZnO nanoparticle
Alavi-Tabari SAR, Khalilzadeh MA, Karimi-Maleh H
Journal of Electroanalytical Chemistry, 811, 84, 2018 |
| 5 |
Co-crystal structures of PTK6: With Dasatinib at 2.24 angstrom, with novel imidazo[1,2-a]pyrazin-8-amine derivative inhibitor at 1.70 angstrom resolution
Thakur MK, Birudukota S, Swaminathan S, Battula SK, Vadivelu S, Tyagi R, Gosu R
Biochemical and Biophysical Research Communications, 482(4), 1289, 2017 |
| 6 |
Redox mechanism, spectrophotometrical characterisation and voltammetric determination in serum samples of kinases inhibitor and anticancer drug dasatinib
Jesus CSH, Diculescu VC
Journal of Electroanalytical Chemistry, 752, 47, 2015 |
